Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
About Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
During the past decade, Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma
2002-07-01
Unknown status
90
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
2004-12-01
2008-07-01
Completed
244
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
2008-04-01
2015-04-01
Completed
791
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno"
#1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
According to Clinical.Site data, the most researched conditions in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are
"Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Lymphoma, T-Cell, Cutaneous" (1 trials). Many other conditions were trialed in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" in a lesser frequency.
Clinical Trials Intervention Types at Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
Most popular intervention types in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "brentuximab vedotin" (2 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
The vast majority of trials in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are
2 trials for "All" genders.
Clinical Trials Status at Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno
Currently, there are NaN active trials in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".